[go: up one dir, main page]

MX2011006803A - Agentes antibacterianos novedosos para el tratamiento de infecciones gram positivas. - Google Patents

Agentes antibacterianos novedosos para el tratamiento de infecciones gram positivas.

Info

Publication number
MX2011006803A
MX2011006803A MX2011006803A MX2011006803A MX2011006803A MX 2011006803 A MX2011006803 A MX 2011006803A MX 2011006803 A MX2011006803 A MX 2011006803A MX 2011006803 A MX2011006803 A MX 2011006803A MX 2011006803 A MX2011006803 A MX 2011006803A
Authority
MX
Mexico
Prior art keywords
compounds
antibacterial agents
treatment
gram positive
novel antibacterial
Prior art date
Application number
MX2011006803A
Other languages
English (en)
Inventor
Jing Li
Andre Lee Pearson
Chester A Metcalf Iii
Original Assignee
Cubist Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cubist Pharm Inc filed Critical Cubist Pharm Inc
Publication of MX2011006803A publication Critical patent/MX2011006803A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/60—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation occurring through the 4-amino group of 2,4-diamino-butanoic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • C07K7/645—Cyclosporins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invención se relaciona con compuestos novedosos de lipopéptidos, las composiciones farmacéuticas de esos compuestos y los métodos para utilizar de esos compuestos como compuestos antibacterianos. Los compuestos de la invención son particularmente útiles contra una variedad de bacterias, entre las que se incluyen cepas resistentes. Los compuestos son útiles como agentes antibacterianos contra Clostridium difficile.
MX2011006803A 2008-12-22 2009-12-18 Agentes antibacterianos novedosos para el tratamiento de infecciones gram positivas. MX2011006803A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13987508P 2008-12-22 2008-12-22
PCT/US2009/068747 WO2010075215A1 (en) 2008-12-22 2009-12-18 Novel antibacterial agents for the treatment of gram positive infections

Publications (1)

Publication Number Publication Date
MX2011006803A true MX2011006803A (es) 2011-09-06

Family

ID=41718893

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2011006803A MX2011006803A (es) 2008-12-22 2009-12-18 Agentes antibacterianos novedosos para el tratamiento de infecciones gram positivas.

Country Status (26)

Country Link
US (3) US8507647B2 (es)
EP (2) EP2674437A1 (es)
JP (1) JP5670914B2 (es)
KR (1) KR101717795B1 (es)
CN (1) CN102325787B (es)
AR (1) AR074833A1 (es)
AU (1) AU2009330245C1 (es)
BR (1) BRPI0923567A2 (es)
CA (1) CA2747965C (es)
CY (1) CY1114883T1 (es)
DK (1) DK2379580T3 (es)
ES (1) ES2442167T3 (es)
HR (1) HRP20131170T1 (es)
IL (1) IL213638A0 (es)
MX (1) MX2011006803A (es)
NZ (1) NZ594019A (es)
PL (1) PL2379580T3 (es)
PT (1) PT2379580E (es)
RS (1) RS53152B (es)
RU (1) RU2512396C2 (es)
SG (1) SG172299A1 (es)
SI (1) SI2379580T1 (es)
SM (1) SMT201400037B (es)
TW (1) TWI444198B (es)
WO (1) WO2010075215A1 (es)
ZA (1) ZA201104693B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2013157188A (ru) * 2011-05-26 2015-07-10 Кьюбист Фармасьютикалз, Инк. Композиции св-183,315 и относящиеся к ним способы
US10377699B2 (en) * 2013-11-06 2019-08-13 The University Of Hong Kong Daptomycin analogues and a method for the preparation of daptomycin or a daptomycin analogue
WO2015172047A1 (en) * 2014-05-08 2015-11-12 Merck Sharp & Dohme Corp. Cyclic peptide compounds and related methods, salts and compositions
US11667674B2 (en) * 2016-04-08 2023-06-06 Versitech Limited Antibacterial cyclic lipopeptides
US10647746B2 (en) 2016-04-08 2020-05-12 Versitech Limited Antibacterial cyclic lipopeptides
HRP20200673T1 (hr) * 2016-04-22 2020-07-10 Astrazeneca Ab Makrociklički inhibitori mcl1 za liječenje raka
US10098890B2 (en) 2016-10-29 2018-10-16 Cipla Limited Stable carfilzomib formulations
IT201600127655A1 (it) 2016-12-16 2018-06-16 Gnosis Spa Processo per la purificazione di antibiotici lipopolipeptidici
US10072045B1 (en) 2017-06-26 2018-09-11 Ramapo Pharmaceuticals, Inc. Antibacterial lipopeptides and methods for their preparation and use
US10526343B2 (en) 2018-03-26 2020-01-07 University Of Sharjah Heterocyclic systems and pharmaceutical applications thereof
RU2762182C1 (ru) * 2020-12-08 2021-12-16 Федеральное государственное бюджетное научное учреждение "Научно-исследовательский институт по изысканию новых антибиотиков имени Г.Ф. Гаузе" Гауземицины А и В - гликолипопептидные антибактериальные антибиотики и способ их получения

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3854480A (en) 1969-04-01 1974-12-17 Alza Corp Drug-delivery system
USRE32455E (en) 1978-10-16 1987-07-07 Eli Lilly And Company A-21978 antibiotics and process for their production
USRE32333E (en) 1978-10-16 1987-01-20 Eli Lilly And Company A-21978 Antibiotics and process for their production
IE55221B1 (en) 1982-02-27 1990-07-04 Beecham Group Plc Antibacterial 1-normon-2-yl-heterocyclic compounds
IL68700A0 (en) * 1982-05-21 1983-09-30 Lilly Co Eli Improvements relating to a-21978c cyclic peptide derivatives and their production
US4396543A (en) * 1982-05-21 1983-08-02 Eli Lilly And Company Derivatives of A-21978C cyclic peptides
US4524135A (en) 1982-05-21 1985-06-18 Eli Lilly And Company A-21978C cyclic peptides
USRE32311E (en) 1982-05-21 1986-12-16 Eli Lilly And Company Derivatives of A-21978C cyclic peptides
US4537717A (en) 1982-05-21 1985-08-27 Eli Lilly And Company Derivatives of A-21978C cyclic peptides
US4482487A (en) 1982-05-21 1984-11-13 Eli Lilly And Company A-21978C cyclic peptides
US4399067A (en) 1982-05-21 1983-08-16 Eli Lilly And Company Derivatives of A-21978C cyclic peptides
USRE32310E (en) 1982-05-21 1986-12-16 Eli Lilly And Company Derivatives of A-21978C cyclic peptides
US4452775A (en) 1982-12-03 1984-06-05 Syntex (U.S.A.) Inc. Cholesterol matrix delivery system for sustained release of macromolecules
ES8700862A1 (es) 1984-10-09 1986-11-16 Lilly Co Eli Un procedimiento para la preparacion de un derivado de a-21978c
CA1315229C (en) 1987-06-10 1993-03-30 Patrick J. Baker Chromatographic purification process
US5039660A (en) 1988-03-02 1991-08-13 Endocon, Inc. Partially fused peptide pellet
DK0460882T3 (da) 1990-06-07 1996-08-26 Lilly Co Eli Lipopeptiddeacylase
AU7497594A (en) 1993-08-13 1995-03-14 Smithkline Beecham Plc Derivatives of monic acids a and c having antibacterial, antimycoplasmatical, antifungal and herbicidal activity
DE4411025A1 (de) 1994-03-30 1995-10-05 Hoechst Ag Lipopeptid-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung
JP3123078B2 (ja) 1996-03-08 2001-01-09 藤沢薬品工業株式会社 環状リポペプチド物質の脱アシル化法
DE19807972A1 (de) 1998-02-25 1999-08-26 Hoechst Marion Roussel De Gmbh Lipopeptidantibiotika-Calciumsalze, Verfahren zu ihrer Herstellung und Verwendung
KR20010075327A (ko) 1998-09-25 2001-08-09 로크리지 스코트 엠 항생제의 투여 방법
AU3434501A (en) 1999-11-03 2001-05-14 Whitaker Corporation, The Optoelectric module for multi-fiber arrays
US7408025B2 (en) 1999-12-15 2008-08-05 Cubist Pharmaceuticals, Inc. Lipopeptides as antibacterial agents
EP2298790A1 (en) 1999-12-15 2011-03-23 Cubist Pharmaceuticals, Inc. Daptomycin analogs as antibacterial agents
JP2003517003A (ja) 1999-12-15 2003-05-20 キュービスト ファーマシューティカルズ， インコーポレイテッド ダプトマイシンアナログおよび抗菌剤としてのそれらの使用
US20060014674A1 (en) * 2000-12-18 2006-01-19 Dennis Keith Methods for preparing purified lipopeptides
CA2456761A1 (en) 2001-08-06 2003-02-20 Cubist Pharmaceuticals, Inc. Novel depsipeptides and process for preparing same
KR20070086038A (ko) * 2004-11-12 2007-08-27 큐비스트 파마슈티컬즈 인코포레이티드 항감염성 리포펩티드

Also Published As

Publication number Publication date
TW201028161A (en) 2010-08-01
WO2010075215A1 (en) 2010-07-01
CN102325787A (zh) 2012-01-18
AU2009330245A1 (en) 2011-08-04
DK2379580T3 (da) 2014-01-20
NZ594019A (en) 2013-08-30
US8507647B2 (en) 2013-08-13
CA2747965C (en) 2017-06-27
IL213638A0 (en) 2011-07-31
PT2379580E (pt) 2014-01-20
EP2674437A1 (en) 2013-12-18
TWI444198B (zh) 2014-07-11
HK1161886A1 (en) 2012-08-10
RU2011130278A (ru) 2013-01-27
EP2379580A1 (en) 2011-10-26
US20140073558A1 (en) 2014-03-13
CN102325787B (zh) 2014-05-28
KR20110114592A (ko) 2011-10-19
AU2009330245C1 (en) 2013-09-26
SI2379580T1 (sl) 2014-02-28
JP2012513467A (ja) 2012-06-14
CY1114883T1 (el) 2016-12-14
HRP20131170T1 (hr) 2014-01-03
EP2379580B1 (en) 2013-10-23
RU2512396C2 (ru) 2014-04-10
BRPI0923567A2 (pt) 2016-09-27
SMT201400037B (it) 2014-05-07
KR101717795B1 (ko) 2017-03-17
ES2442167T3 (es) 2014-02-10
ZA201104693B (en) 2013-01-30
US20150337013A1 (en) 2015-11-26
CA2747965A1 (en) 2010-07-01
JP5670914B2 (ja) 2015-02-18
AR074833A1 (es) 2011-02-16
PL2379580T3 (pl) 2014-05-30
AU2009330245B2 (en) 2013-05-02
RS53152B (sr) 2014-06-30
US20100184649A1 (en) 2010-07-22
SG172299A1 (en) 2011-07-28

Similar Documents

Publication Publication Date Title
MX2011006803A (es) Agentes antibacterianos novedosos para el tratamiento de infecciones gram positivas.
WO2010063996A3 (en) Antibacterial compounds
CA2747703C (en) Compositions and methods for the treatment or the prevention of infections by e. coli
NZ593892A (en) Antibiotic compositions for the treatment of gram negative infections
NZ708928A (en) Mannose derivatives for treating bacterial infections
WO2010090860A3 (en) Methods and compositions for treating bacterial infection
GB2480772A (en) Compositions and methods for the treatment or prevention of staphylococcus aureus infections and for the eradication or reduction of staphylococcus aureus
WO2011005341A3 (en) Compositions and methods related to protein a (spa) variants
EA033311B1 (ru) Производные бензоксаборола в качестве антибактериальных средств
MX2013000369A (es) Composiciones para el tratamiento de infecciones de pulmon, formuladas para ser administrables mediante aerolizacion, y que incluyen tobramicina.
MX2011008043A (es) Derivados de actagardina.
WO2010151784A3 (en) Antimicrobial compounds
NZ602544A (en) Crystalline forms of a macrolide, and uses therefor
MX363478B (es) 3,4-dihidro-1h-[1,8]naftiridinosas sustituidas con piperidinilo antibacterianas.
PH12014500317A1 (en) Antibacterial cyclopenta[c]pyrrole substituted 3,4-dihydro-1h-[1,8]naphthyridinones
WO2011029536A3 (de) Verwendung von cyclischen ketoenolen gegen pflanzenpathogene bakterien
WO2012177075A3 (ko) 항생제 및 라이소포스파티딜콜린을 포함하는 면역 증강 또는 세균성 감염 질환 치료용 조성물
MX2009009074A (es) Macrolidos basados en eritromicina.
MX2015008373A (es) Peptidos antimicrobianos, composiciones que los comprende y usos.
MX337145B (es) Composiciones farmaceuticas.
SG178936A1 (en) Compositions and methods for treating bacterial infections using ceftaroline
WO2010086617A3 (en) Phosphoantigens for the treatment of burkholderia infections
PH12015501428A1 (en) Antibacterial compounds
UA110098C2 (uk) Композиція, що містить цефтаролін фозамілу, для лікування бактеріальної інфекції
PH12013501069A1 (en) Pharmaceutical compositions

Legal Events

Date Code Title Description
FG Grant or registration